BNP/CALL/SARTORIUS STEDIM BIO/220/0.01/20.12.24 Share Price

Warrant

DE000PC1ME99

Market Closed - Börse Stuttgart 09:12:55 28/05/2024 BST
0.16 EUR -11.11% Intraday chart for BNP/CALL/SARTORIUS STEDIM BIO/220/0.01/20.12.24
Current month-33.33%
1 month-35.71%
Date Price Change
28/05/24 0.16 -11.11%
27/05/24 0.18 +12.50%
24/05/24 0.16 -15.79%
23/05/24 0.19 +5.56%
22/05/24 0.18 -10.00%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 09:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1ME9
ISINDE000PC1ME99
Date issued 11/12/2023
Strike 220
Maturity 20/12/2024 (206 Days)
Parity 100 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.8
Lowest since issue 0.16
Delta0.41x
Omega 4.765
Premium26.54x
Gearing11.66x
Moneyness 0.8477
Difference Strike 33.5
Difference Strike %+15.23%
Spread 0.02
Spread %11.76%
Theoretical value 0.1600
Implied Volatility 46.96 %
Total Loss Probability 72.02 %
Intrinsic value 0.000000
Present value 0.1600
Break even 236.00 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
186.5 EUR
Average target price
248.8 EUR
Spread / Average Target
+33.42%
Consensus